New vaccine cuts return of skin cancer by half

A personalized vaccine developed by Merck & Co. and Moderna Inc. helped prevent the recurrence of severe skin cancer for three years in promising new results from a study.

Related Keywords

,Gerry Smith Bloomberg ,Stephen Hoge ,Fiona Rutherford ,Bloomberg ,Moderna Inc ,Merck Co ,Gerry Smith ,President Stephen Hoge ,